par Kalykaki, A.;Vamvakas, L;Agelaki, Sofia;Kalbakis, K;Vardakis, N;Sfakiotaki, G;Ignatiadis, Michail ;Saridaki, Z.;Karampeazis, A;Karabeazis, A;Mavroudis, Dimitris;Georgoulias, Vassilis
Référence Oncology, 71, 3-4, page (197-203)
Publication Publié, 2006
Référence Oncology, 71, 3-4, page (197-203)
Publication Publié, 2006
Article révisé par les pairs
Titre: |
|
Auteur: | Kalykaki, A.; Vamvakas, L; Agelaki, Sofia; Kalbakis, K; Vardakis, N; Sfakiotaki, G; Ignatiadis, Michail; Saridaki, Z.; Karampeazis, A; Karabeazis, A; Mavroudis, Dimitris; Georgoulias, Vassilis |
Informations sur la publication: | Oncology, 71, 3-4, page (197-203) |
Statut de publication: | Publié, 2006 |
Sujet CREF: | Cancérologie |
Médecine pathologie humaine | |
Sciences bio-médicales et agricoles | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- therapeutic use | |
Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives | |
Female | |
Glutamates -- administration & dosage -- adverse effects | |
Guanine -- administration & dosage -- adverse effects -- analogs & derivatives | |
Humans | |
Male | |
Maximum Tolerated Dose | |
Middle Aged | |
Neoplasms -- drug therapy | |
Pemetrexed | |
Langue: | Anglais |
Identificateurs: | urn:issn:0030-2414 |
info:doi/10.1159/000106069 | |
info:pii/000106069 | |
info:pmid/17641541 |